🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ting Su

Donghua University

ORCID: 0000-0001-5254-1595

Also affiliated with NeuroMedical Center, University of South China

Immunology and MicrobiologyBiochemistry, Genetics and Molecular BiologyMedicineEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer”.

A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer

Science Advances(2020)10.1126/sciadv.aaw6071
N/A
0DataRank · unranked
273 citations

Fuwu Zhang, Yijing Liu, Zhantong Wang, Guocan Yu, Brian Liang +7 more

Polymeric micelles amplify tumor oxidative stresses through combining PDT and glutathione depletion for synergistic cancer chemotherapy

Chemical Engineering Journal(2021)10.1016/j.cej.2021.128561
N/A
0DataRank · unranked
60 citations

Furong Cheng, Yuji Pu, Jun Cao, Shuibin Lin, Guizhi Zhu +2 more

Responsive Multivesicular Polymeric Nanovaccines that Codeliver STING Agonists and Neoantigens for Combination Tumor Immunotherapy

Advanced Science(2022)10.1002/advs.202201895
N/A
0DataRank · unranked
75 citations

Furong Cheng, Jialong Qi, Yu Zhang, Shurong Zhou, Lei Mei +5 more

Engineering and Delivery of cGAS-STING Immunomodulators for the Immunotherapy of Cancer and Autoimmune Diseases

Accounts of Chemical Research(2023)10.1021/acs.accounts.3c00394
N/A
0DataRank · unranked
75 citations

Furong Cheng, Yu Zhang, Ting Su, Guizhi Zhu, Shurong Zhou

Single-dose injectable nanovaccine-in-hydrogel for robust immunotherapy of large tumors with abscopal effect

Science Advances(2023)10.1126/sciadv.ade6257
N/A
0DataRank · unranked
73 citations

Ting Su, Shurong Zhou, Xiang Liu, Suling Yang, Shuibin Lin +3 more

Targeting Lymph Nodes for Systemic Immunosuppression Using Cell‐Free‐DNA‐Scavenging And cGAS‐Inhibiting Nanomedicine‐In‐Hydrogel for Rheumatoid Arthritis Immunotherapy

Advanced Science(2023)10.1002/advs.202302575
N/A
0DataRank · unranked
47 citations

Ting Su, Yangtengyu Liu, Shurong Zhou, Jialong Qi, Weisheng Guo +2 more

Lymph node-targeting adjuvant/neoantigen-codelivering vaccines for combination glioblastoma radioimmunotherapy

Theranostics(2023)10.7150/thno.84443
N/A
0DataRank · unranked
7 citations

Shurong Zhou, Suling Yang, Nicholas Humble, Fuwu Zhang, Guocan Yu +5 more

Engineering cGAS-agonistic oligonucleotides as therapeutics and vaccine adjuvants for cancer immunotherapy

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.07.13.548237
N/A
0DataRank · unranked
4 citations

Ting Su, Furong Cheng, Janét Cole, Xiang Liu, Bei Zhang +4 more

Engineering cGAS-agonistic oligonucleotides as therapeutics for cancer immunotherapy

Molecular Therapy — Nucleic Acids(2024)10.1016/j.omtn.2024.102126
N/A
0DataRank · unranked
19 citations

Ting Su, Furong Cheng, Janét Cole, Xiang Liu, Bei Zhang +4 more

Proteolysis-targeting vaccines (PROTAVs) for robust combination immunotherapy of melanoma

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.10.01.616069
N/A
0DataRank · unranked
0 citations

Ting Su, Furong Cheng, Shurong Zhou, Xiang Liu, Mi Wang +15 more

Small circular RNAs as vaccines for cancer immunotherapy

Nature Biomedical Engineering(2025)10.1038/s41551-025-01344-5
N/A
0DataRank · unranked
63 citations

Xiang Liu, Tingting Shen, Qiyan Wang, Shurong Zhou, Suling Yang +14 more

Combined cancer immunotherapy with lipid nanoparticle delivery of oligo-based cGAS-agonistic adjuvant and peptide or mRNA vaccines

Molecular Therapy — Nucleic Acids(2025)10.1016/j.omtn.2025.102623
N/A
0DataRank · unranked
12 citations

Yuqing Liang, Yu Hao, Qiyan Wang, You Xu, Ting Su +3 more